Aberration of p53 and DCC in gastric and colorectal cancer

Oncology Reports

Volumn 7, Issue 1, 2000, Pages 99-103

  Kataoka, Masafumi ^a   Okabayashi, Takahiro ^a   Johira, Hiroki ^a   Nakatani, Shin ^a   Nakashima, Akira ^a   Takeda, Akira ^a   Nishizaki, Masahiko ^a   Orita, Kunzo ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Deleted in colorectal carcinoma gene; Gastric cancer; p53

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ARTICLE; COLORECTAL TUMOR; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; GENES, DCC; HUMANS; IMMUNOHISTOCHEMISTRY; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033630041     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.1.99     Document Type: Article

References (12)

1. Weinberg RA: Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49: 3713-3721, 1989.
2. Bishop JM: The molecular genetics of cancer. Science 235: 305-311, 1987.
3. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
4. Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
5. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Prop Natl Acad Sci USA 89: 7491-7495, 1992.
6. Yonish RE, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
7. Shaw P, Bovey R, Tardy S, Sacli R, Sordat B and Costa J: Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89: 4495-4499, 1992.
8. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935, 1992.
9. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948, 1992.
10. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T and Hirohashi S: Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52: 3099-3102,1992.
11. Iwaya K, Tsuda H, Hiraide H, Tamaki K, Tamakuma S, Fukutomi T, Mukai K and Hirohashi S: Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res 82: 835-840, 1991.
12. Davidoff AM, Herndon JD, Glover NS, Kerns BJ, Pence JC, Iglehart JD and Marks JR: Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 110: 259-264, 1991.